Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (Pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.

被引：0
|
作者：
West, H
Belt, RJ
Wakelee, HA
Bloss, LP
Taylor, L
Monberg, MJ
Ye, Z
Obasaju, CK
机构：
[1] Swedish Canc Inst, Seattle, WA USA
[2] Kansas City Canc Ctr, Kansas City, MO USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：649S / 649S
页数：1
相关论文
共 50 条
  • [31] A phase II trial of biweekly administration of vinorelbine (V) and gemcitabine (G) in elderly patients (Pts) with advanced non-small cell lung cancer (NSCLC).
    Kimura, H
    Kasahara, K
    Shibata, K
    Shirasaki, H
    Iwasa, K
    Yoshimoto, A
    Kita, T
    Fuzimura, M
    Nakao, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 698S - 698S
  • [32] A phase II trial of thalidomide (T), irinotecan (I) and gemcitabine (G) in chemonaive patients (pts) with advanced non-small cell lung cancer (NSCLC).
    Flora, DB
    Kleykamp, B
    Knapp, M
    Shukla, R
    Jazieh, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 680S - 680S
  • [33] Single-agent pemetrexed or sequential pemetrexed/gemcitabine as front-line treatment of advanced non-small cell lung cancer in elderly patients or patients ineligible for platinum-based chemotherapy:: A multicenter, randomized, phase II trial
    Gridelli, Cesare
    Kaukel, Eckhard
    Gregorc, Vanessa
    Migliorino, Maria Rita
    Mueller, Thomas R.
    Manegold, Christian
    Favaretto, Adolfo
    Martoni, Andrea
    Caffo, Orazio
    Schmittel, Alexander
    Rossi, Antonio
    Russo, Francesca
    Peterson, Patrick
    Munoz, Maria
    Reck, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (03) : 221 - 229
  • [34] Phase II trial of alternate schedule of chemotherapy as front-line treatment in metastatic non-small cell lung cancer (NSCLC): A single-centre experience
    Lopez Castro, R.
    Martin, G.
    Seijas, R.
    Bellido, L.
    del Barco, E.
    Garcia, R.
    Martin, T.
    Castro, E.
    Leno, R.
    Cruz, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] Docetaxel versus docetaxel plus irinotecan as second line chemotherapy in advanced non-small cell lung cancer (NSCLC): A randomized phase II trial.
    Pectasides, D
    Farmakis, D
    Pectasides, M
    Kostopoulou, V
    Nikolaou, M
    Koumpou, M
    Gaglia, A
    Kountourakis, P
    Mylonakis, N
    Economopoulos, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 625S - 625S
  • [36] Meta-analysis of pemetrexed (P) plus gemcitabine (G) in first-line, advanced (adv) non-small cell lung cancer (NSCLC)
    Ye, Z.
    Treat, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [37] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Yun Fan
    Neng-ming Lin
    Sheng-lin Ma
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    Acta Pharmacologica Sinica, 2010, 31 : 746 - 752
  • [38] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [39] Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: A randomized, multicenter phase III trial
    Georgoulias, Vassilis
    Androulakis, Nikolaos
    Kotsakis, Athanasios
    Hatzidaki, Dora
    Syrigos, Kostas
    Polyzos, Aris
    Agelidou, Athina
    Varthalitis, Loannis
    Ziras, Nikoalos
    Agelidou, Maria
    Chandrinos, Vassilis
    Boukovinas, Loannis
    Geroyianni, Alexandra
    Vamakas, Larnbros
    Mavroudis, Dirnitris
    LUNG CANCER, 2008, 59 (01) : 57 - 63
  • [40] Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
    Georgoulias, V
    Kouroussis, C
    Androulakis, N
    Kakolyris, S
    Dimopoulos, MA
    Papadakis, E
    Bouros, D
    Apostolopoulou, F
    Papadimitriou, C
    Agelidou, A
    Hatzakis, K
    Kalbakis, K
    Kotsakis, A
    Vardakis, N
    Vlachonicolis, J
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 914 - 920
12345